Aromatase inhibitor use, side effects and discontinuation rates in gynecologic oncology patients

OBJECTIVE. Aromatase inhibitors (AI) are frequently prescribed in gynecologic oncology. We sought to define the frequency and duration of AI use, characterize AI side effects and determine the reasons for discontinuation in these patients. METHODS. Uterine and ovarian cancer patients with AI use for...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Sarah G., Dalton, Liam, McNeish, Brendan L., Fang, Fang, Henry, N. Lynn, Kidwell, Kelley M., McLean, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036903/
https://www.ncbi.nlm.nih.gov/pubmed/32847676
http://dx.doi.org/10.1016/j.ygyno.2020.08.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036903/
https://www.ncbi.nlm.nih.gov/pubmed/32847676
http://dx.doi.org/10.1016/j.ygyno.2020.08.015

Ejemplares similares